Skip to content
Clinical Trials – home
Shanghai Junshi Biosciences Co. Ltd.
Sponsor

Shanghai Junshi Biosciences Co. Ltd.

Building 2 13th Floor, No. 36 And 58 Haiqu Road, Pudong New Area, 201203

About the sponsor

Clinical research in limited-stage small cell lung cancer focuses on patients without disease progression after chemoradiotherapy, with interest in consolidation therapy and survival outcomes such as overall survival and progression-free survival.

  • Limited-stage small cell lung cancer
  • Consolidation therapy
  • Overall survival
  • Progression-free survival

Research activities in this area include immunotherapy-based combinations for post-chemoradiotherapy disease control.

About Specializations

Shanghai Junshi Biosciences Co. Ltd. runs clinical trials in conditions such as Small cell lung cancer limited stage, Hepatocellular carcinoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Study on Toripalimab and Tifcemalimab for Patients with Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Tifcemalimab
  • Sponsor:Shanghai Junshi Biosciences Co. Ltd.

Study Comparing Toripalimab and Lenvatinib with Placebo and Lenvatinib for First-Line Treatment in Patients with Advanced Liver Cancer

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Lenvatinib
  • Sponsor:Shanghai Junshi Biosciences Co. Ltd.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.